Names and pronunciation
(nye-vol′ue-mab) Opdivo
PDF page 961
Drug reference
(nye-vol′ue-mab) Opdivo
PDF page 961
Func. class.: Antineoplastic, monoclo- nal antibody
PDF page 961
USES: Treatment of BRAF V600 muta- tion-positive unresectable/metastatic mela- noma, Hodgkin’s disease, non–small-cell lung cancer (NSCLC), renal cell cancer, mesothelioma
PDF page 961
CONTRAINDICATIONS: Hyper- sensitivity
PDF page 961
DOSAGE AND ROUTES • Adult: IV INFUSION 240 mg over 30 min q2wk OR 480 mg over 30 min q4wk, until disease progression or unaccept- able toxicity
PDF page 961
Available forms: Injection 10 mg/mL
PDF page 961
• Adult: IV INFUSION 240 mg over 30 min q2wk OR 480 mg over 30 min q4wk, until disease progression or unaccept- able toxicity
PDF page 961